If this email is not displayed correctly please click here

Healthcare & Life Sciences

19 June 2019
Katie Lee Federal Court dismisses Servier's application for order of prohibition regarding salt patent

Canada - Smart & Biggar

The Federal Court recently dismissed Servier's application for a prohibition order under the pre-amended Patented Medicines (Notice of Compliance) Regulations for Canadian Patent 2,423,825 regarding a perindopril arginine/amlodipine product (Servier's Viacoram). Apotex had alleged that the patent was invalid for obviousness, overbreadth, inutility and insufficiency.

Author: Katie Lee
Read more
Abigail Smith Court upholds issuance of NON-W letter and cancellation of reconsideration process for Apotex

Canada - Smart & Biggar

The Federal Court of Appeal recently affirmed the Federal Court's dismissal of Apotex's application for judicial review of a minister of health decision relating to its Apo-Omeprazole (omeprazole magnesium) delayed-release tablets. The minister had issued a Notice of Non-Compliance – Withdrawal letter in respect of Apotex's abbreviated new drug submission on the basis that the tablets were not bioequivalent to the relevant Canadian reference product.

Author: Abigail Smith
Read more

Recent updates

Abigail Smith Ontario Court of Appeal overturns ban on online sales of prescription eyewear to Ontario residents

Canada - Smart & Biggar

Author: Abigail Smith
Riccardo Fruscalzo Legislative decree opens way to commercial use of data obtained by non-profit clinical trials

Italy - Hogan Lovells

Authors: Riccardo Fruscalzo, Carlotta Busani
James M Perez Rule 9(b)'s particularity requirement and constitutionality of False Claims Act qui tam provisions

USA - Sidley Austin LLP

Authors: James M Perez, Andrew B Talai, Nisha Chandran